ZEPP vs. AMIX, NEUE, GANX, BLRX, AADI, ICCM, LUCD, ENZ, ELDN, and AVRO
Should you be buying Zepp Health stock or one of its competitors? The main competitors of Zepp Health include Autonomix Medical (AMIX), NeueHealth (NEUE), Gain Therapeutics (GANX), BioLineRx (BLRX), Aadi Bioscience (AADI), IceCure Medical (ICCM), Lucid Diagnostics (LUCD), Enzo Biochem (ENZ), Eledon Pharmaceuticals (ELDN), and AVROBIO (AVRO). These companies are all part of the "medical" sector.
Autonomix Medical (NASDAQ:AMIX) and Zepp Health (NYSE:ZEPP) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their community ranking, institutional ownership, analyst recommendations, earnings, valuation, profitability, risk, dividends and media sentiment.
In the previous week, Zepp Health had 2 more articles in the media than Autonomix Medical. MarketBeat recorded 5 mentions for Zepp Health and 3 mentions for Autonomix Medical. Zepp Health's average media sentiment score of 0.93 beat Autonomix Medical's score of 0.49 indicating that Autonomix Medical is being referred to more favorably in the media.
Zepp Health received 2 more outperform votes than Autonomix Medical when rated by MarketBeat users.
Zepp Health has a consensus price target of $4.96, suggesting a potential upside of 475.74%. Given Autonomix Medical's higher probable upside, analysts clearly believe Zepp Health is more favorable than Autonomix Medical.
10.8% of Autonomix Medical shares are owned by institutional investors. Comparatively, 52.6% of Zepp Health shares are owned by institutional investors. 36.0% of Zepp Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Autonomix Medical has higher earnings, but lower revenue than Zepp Health.
Autonomix Medical has a net margin of 0.00% compared to Autonomix Medical's net margin of -8.66%. Zepp Health's return on equity of 0.00% beat Autonomix Medical's return on equity.
Summary
Zepp Health beats Autonomix Medical on 7 of the 12 factors compared between the two stocks.
Get Zepp Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for ZEPP and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ZEPP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Zepp Health Competitors List
Related Companies and Tools
